Stock listing
Munich:EII Eisai Co., Ltd. Aktie
German listing (Munich) of Eisai Co., Ltd. · home listing Tokyo:4523
Follow Eisai Co., Ltd. into a list and get an email when it puts out news.
Share price · MUN:EII
€30.06 EUR +0.01 (+0.0%)
Close on Nov 20, 2026
- Day range
- €30.06 – €30.06 EURNov 20, 2026
- Market cap
- €16.41B EURAt the close on Nov 20, 2026 · price × 545.9M shares outstanding
- 52-week range
- €20.14 – €31.47 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- €2,192 EURMedian day 0 shares · 48 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| OTC:ESAIY | $8.28 USD | +0.06 (+0.7%) | 500 | $8.25 | $8.28 | $8.25 | $8.22 | Close on Nov 20, 2026 |
| OTC:ESALF | $33.06 USD | +0.48 (+1.5%) | 200 | $33.06 | $33.06 | $33.06 | $32.58 | Close on Nov 16, 2026 |
| Frankfurt:EII | €29.71 EUR | -1.04 (-3.4%) | — | €29.61 | €29.71 | €29.61 | €30.75 | Close on Nov 20, 2026 |
| Munich:EII | €30.06 EUR | +0.01 (0.0%) | — | €30.06 | €30.06 | €30.06 | €30.05 | Close on Nov 20, 2026 |
| Dusseldorf:EII | €29.49 EUR | -0.27 (-0.9%) | — | €30.00 | €30.00 | €29.49 | €29.76 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 6, 2026 · MUN:EII · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €27.72 | -3.274 | -10.6% | €27.72 | €27.72 | €27.72 | 0 | |
| €30.99 | +2.507 | +8.8% | €29.44 | €31.47 | €29.43 | 300 | |
| €28.48 | -0.119 | -0.4% | €28.48 | €28.48 | €28.48 | 0 | |
| €28.60 | -0.025 | -0.1% | €28.60 | €28.60 | €28.60 | 0 | |
| €28.63 | -0.20 | -0.7% | €28.58 | €28.88 | €28.55 | 800 | |
| €28.83 | +0.469 | +1.7% | €28.78 | €28.85 | €28.76 | 81 | |
| €28.36 | -0.615 | -2.1% | €28.36 | €28.36 | €28.36 | 0 | |
| €28.97 | -0.313 | -1.1% | €28.97 | €28.97 | €28.97 | 0 | |
| €29.29 | +0.06 | +0.2% | €29.29 | €29.29 | €29.29 | 0 | |
| €29.23 | +0.142 | +0.5% | €29.28 | €29.33 | €29.22 | 1,130 | |
| €29.09 | +1.062 | +3.8% | €28.90 | €29.41 | €28.90 | 710 | |
| €28.02 | +0.026 | +0.1% | €28.02 | €28.02 | €28.02 | 0 | |
| €28.00 | +0.35 | +1.3% | €28.00 | €28.00 | €28.00 | 0 | |
| €27.65 | +0.116 | +0.4% | €27.65 | €27.65 | €27.65 | 0 | |
| €27.53 | +0.184 | +0.7% | €27.53 | €27.53 | €27.53 | 0 | |
| €27.35 | +0.464 | +1.7% | €27.35 | €27.35 | €27.35 | 0 | |
| €26.88 | +0.692 | +2.6% | €26.88 | €26.88 | €26.88 | 0 | |
| €26.19 | +0.036 | +0.1% | €26.19 | €26.19 | €26.19 | 0 | |
| €26.16 | -0.057 | -0.2% | €26.16 | €26.16 | €26.16 | 0 | |
| €26.21 | +0.07 | +0.3% | €26.21 | €26.21 | €26.21 | 0 | |
| €26.14 | -0.222 | -0.8% | €26.14 | €26.14 | €26.14 | 0 | |
| €26.36 | -0.15 | -0.6% | €26.36 | €26.36 | €26.36 | 0 | |
| €26.51 | -0.08 | -0.3% | €26.51 | €26.51 | €26.51 | 0 | |
| €26.59 | +0.019 | +0.1% | €26.59 | €26.59 | €26.59 | 0 | |
| €26.58 | -0.123 | -0.5% | €26.58 | €26.58 | €26.58 | 0 | |
| €26.70 | -0.437 | -1.6% | €26.70 | €26.70 | €26.70 | 0 | |
| €27.14 | +0.252 | +0.9% | €27.14 | €27.14 | €27.14 | 0 | |
| €26.88 | -0.17 | -0.6% | €26.97 | €27.29 | €26.88 | 100 | |
| €27.05 | -0.161 | -0.6% | €27.05 | €27.05 | €27.05 | 0 | |
| €27.21 | +0.07 | +0.3% | €27.21 | €27.21 | €27.21 | 0 | |
| €27.14 | -0.196 | -0.7% | €27.14 | €27.14 | €27.14 | 0 | |
| €27.34 | +0.013 | 0.0% | €27.34 | €27.34 | €27.34 | 0 | |
| €27.33 | -0.321 | -1.2% | €27.33 | €27.33 | €27.33 | 0 | |
| €27.65 | +0.309 | +1.1% | €27.65 | €27.65 | €27.65 | 0 | |
| €27.34 | -0.316 | -1.1% | €27.34 | €27.34 | €27.34 | 0 | |
| €27.66 | +0.032 | +0.1% | €27.66 | €27.66 | €27.66 | 0 | |
| €27.62 | +0.011 | 0.0% | €27.62 | €27.62 | €27.62 | 0 | |
| €27.61 | +1.27 | +4.8% | €26.69 | €27.76 | €26.46 | 1,200 | |
| €26.34 | -0.08 | -0.3% | €26.34 | €26.34 | €26.34 | 0 | |
| €26.42 | +0.682 | +2.6% | €26.42 | €26.42 | €26.42 | 0 | |
| €25.74 | -0.06 | -0.2% | €25.74 | €25.74 | €25.74 | 0 | |
| €25.80 | +0.075 | +0.3% | €25.80 | €25.80 | €25.80 | 0 | |
| €25.73 | -0.291 | -1.1% | €25.73 | €25.73 | €25.73 | 0 | |
| €26.02 | +0.31 | +1.2% | €26.02 | €26.02 | €26.02 | 0 | |
| €25.71 | -0.537 | -2.0% | €25.71 | €25.71 | €25.71 | 0 | |
| €26.24 | +0.285 | +1.1% | €26.22 | €26.26 | €26.17 | 10 | |
| €25.96 | +0.298 | +1.2% | €25.96 | €25.96 | €25.96 | 0 | |
| €25.66 | -0.278 | -1.1% | €25.66 | €25.66 | €25.66 | 0 | |
| €25.94 | +0.173 | +0.7% | €25.94 | €25.94 | €25.94 | 0 | |
| €25.77 | -0.266 | -1.0% | €25.77 | €25.77 | €25.77 | 0 | |
| €26.03 | -0.151 | -0.6% | €26.03 | €26.03 | €26.03 | 0 | |
| €26.18 | -0.274 | -1.0% | €26.18 | €26.18 | €26.18 | 0 | |
| €26.46 | +0.217 | +0.8% | €26.46 | €26.46 | €26.46 | 0 | |
| €26.24 | -0.287 | -1.1% | €26.24 | €26.24 | €26.24 | 0 | |
| €26.53 | +0.086 | +0.3% | €26.58 | €26.59 | €26.32 | 25 | |
| €26.44 | +0.043 | +0.2% | €26.44 | €26.44 | €26.44 | 0 | |
| €26.40 | +0.46 | +1.8% | €26.40 | €26.40 | €26.40 | 0 |
- Ticker
- Munich:EII
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- Munich
- Currency
- EUR
What changed lately
Latest news release · Nov 12, 2026
LEQEMBI Pen (Subcutaneous Formulation of LEQEMBI) Now Available in Japan for Patients with Early Alzheimer’s Disease
Latest earnings call · Aug 3, 2026
Eisai (Tokyo:4523) Q1 2027 Earnings Call
Replay and transcript
Latest deck · Nov 10, 2026
Q2 2027 Earnings Presentation
Earnings · 33 slides
Latest news
Revenue of LEQEMBI (Preliminary Basis)
Oct 28, 2026
Closed €28.97 (-1.1%) on Oct 28, 2026
Notification Regarding Receipt of Dividend from a Consolidated Subsidiary
Oct 2, 2026
Closed €26.70 (-1.6%) on Oct 2, 2026
U.S. FDA Approves WELIREG® (belzutifan) Plus LENVIMA® (lenvatinib) for Certain Previously Treated Adult Patients With Advanced Renal Cell Carcinoma With a Clear Cell Component (ccRCC)
Sep 25, 2026
Closed €27.14 (-0.7%) on Sep 25, 2026
Leqembi® Pen subcutaneous formulation approved in Japan
Sep 16, 2026
Closed €27.61 (+4.8%) on Sep 16, 2026
LEQEMBI® Pen (Subcutaneous Formulation of LEQEMBI®) Approved in Japan for the Treatment of Early Alzheimer’s Disease
Sep 16, 2026
Closed €27.61 (+4.8%) on Sep 16, 2026
Eisai and Osaka Prefecture Enter into Collaboration to Promote Awareness of Dementia and Mild Cognitive Impairment (MCI)
Sep 15, 2026
Closed €26.34 (-0.3%) on Sep 15, 2026
LEQEMBI (lecanemab) Subcutaneous Formulation as an Initiation Treatment for Early Alzheimer’s Disease Approved in China
Sep 3, 2026
Closed €25.96 (+1.2%) on Sep 3, 2026
Eisai Co., Ltd. on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 59 in the last 12 months · 89 in all · newest Nov 12, 2026 · oldest 2025
- Calls
- 8 calls with a replay · 8 with a transcript · latest Aug 3, 2026
- Decks
- 9 decks · latest Nov 10, 2026
Where Eisai Co., Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Tokyo:4523 エーザイ · Home listing | Tokyo | Japan | JPY |
| OTC:ESAIY | OTC | United States | USD |
| gettex:EII | gettex | Germany | EUR |
| OTC:ESALF | OTC | United States | USD |
| Tradegate:EII | Tradegate | Germany | EUR |
| LS Exchange:855526 | LS Exchange | Germany | EUR |
| Frankfurt:EII | Frankfurt | Germany | EUR |
| Lang & Schwarz:855526 | Lang & Schwarz | Germany | EUR |
| Hamburg:EII | Hamburg | Germany | EUR |
| Hanover:EII | Hanover | Germany | EUR |
| Munich:EII · This page | Munich | Germany | EUR |
| Dusseldorf:EII | Dusseldorf | Germany | EUR |
| BIVA:4523N | BIVA | Mexico | MXN |
| BMV:4523N | BMV | Mexico | MXN |
| Dusseldorf:EIIA | Dusseldorf | Germany | EUR |
| Frankfurt:EIIA | Frankfurt | Germany | EUR |
| Stuttgart:EII | Stuttgart | Germany | EUR |
Team and board
| Officer | Role |
|---|---|
| Eisai Co | Ltd. Investor Relations Department |
| Jenny Ljunggren | External Communications and Investor Relations ManagerE-mail: [email protected] |
| Oskar Bosson | VP Communications and Investor RelationsE-mail: [email protected] |
Events
| Call | When | Status |
|---|---|---|
| Eisai (Tokyo:4523) Q1 2027 Earnings Call | Mon, Aug 03, 2026 · 3:00 AM ET | Replay |
| Eisai (Tokyo:4523) Q4 2026 Earnings Call | Fri, May 15, 2026 · 3:00 AM ET | Replay |
| Eisai (Tokyo:4523) Q2 2026 Earnings Call | Fri, Nov 07, 2025 · 2:30 AM ET | Replay |
| Eisai (Tokyo:4523) Q1 2026 Earnings Call | Tue, Aug 05, 2025 · 2:30 AM ET | Replay |
| Eisai (Tokyo:4523) Q4 2025 Earnings Call | Thu, May 15, 2025 · 2:30 AM ET | Replay |
| Eisai (Tokyo:4523) Q2 2025 Earnings Call | Fri, Nov 08, 2024 · 1:00 AM ET | Replay |
| Eisai (Tokyo:4523) Q1 2025 Earnings Call | Fri, Aug 02, 2024 · 2:00 AM ET | Replay |
| Eisai (Tokyo:4523) Q4 2024 Earnings Call | Thu, May 16, 2024 · 2:00 AM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 2027 Earnings Presentation | Earnings | 33 slides | Nov 10, 2026 |
| Q2 FY2026 Earnings Presentation | Earnings | 33 slides | Nov 10, 2026 |
| Q1 2027 Earnings Presentation | Earnings | 30 slides | Aug 3, 2026 |
| FY2025 Earnings Presentation | Earnings | 37 slides | May 15, 2026 |
| Corporate Update (November 2025) | Corporate update | 22 slides | Nov 13, 2025 |
| Q2 2026 Earnings Presentation | Earnings | 37 slides | Nov 7, 2025 |
| Fact Sheet (May 2014) | Fact sheet | 1 slide | May 2014 |
| Fact Sheet (March 2013) | Fact sheet | 1 slide | March 2013 |
| Fact Sheet (June 2011) | Fact sheet | 2 slides | June 2011 |
Filings
Cap table
Built by 6ix from Eisai Co., Ltd.’s releases
- Common shares
- 291,649,149
- Fully diluted
- 291,649,149
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 291,649,149 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 291,649,149 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Eisai Co Other companies: Nuvation Bio Inc. (Ltd. Investor Relations Department · Since at least Mar 26, 2026); Biogen Inc. (Investor Relations Department · Since at least Jan 25, 2026) | Ltd. Investor Relations Department · Since at least Mar 26, 2026 |
| Jenny Ljunggren | External Communications and Investor Relations ManagerE-mail: [email protected] · Since at least Sep 16, 2026 |
| Oskar Bosson | VP Communications and Investor RelationsE-mail: [email protected] · Since at least Sep 16, 2026 |
Log in to ask 6ix AI your own questions about Eisai Co., Ltd.